Oncotelic Therapeutics, Inc. Proceeds from Notes Payable
Oncotelic Therapeutics, Inc. (OTLC) reported Proceeds from Notes Payable of $1.82 million for the 12-month period ending 2021-12-31, per its 10-K/A filed 2023-04-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2023-04-20
- Oncotelic Therapeutics, Inc. proceeds from notes payable for fiscal 2021 was $1.82M.
| Period end | Proceeds from Notes Payable 0 month | Proceeds from Notes Payable 12 month |
|---|---|---|
| 2021-12-31 | $1.82M 10-K/A · filed 2023-04-20 | |
| 2021-06-30 | $100.00K 10-Q · filed 2021-08-20 |